{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:52:05Z","timestamp":1792266725713,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["20244Y0021"],"award-info":[{"award-number":["20244Y0021"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004241","name":"China Primary Health Care Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008750","name":"Shanghai Municipal Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC12023116"],"award-info":[{"award-number":["SHDC12023116"]}],"id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Ophthalmology Practice and Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.aopr.2026.03.004","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T19:14:18Z","timestamp":1774466058000},"page":"319-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of the efficacy and safety of conbercept plus panretinal photocoagulation versus panretinal photocoagulation alone for proliferative diabetic retinopathy: A multicenter, prospective, randomized controlled study"],"prefix":"10.1016","volume":"6","author":[{"given":"Wenyi","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guisen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zipei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gezhi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aopr.2026.03.004_bib1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.aopr.2026.03.004_bib2","article-title":"Different lasers and techniques for proliferative diabetic retinopathy","volume":"3","author":"Moutray","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.aopr.2026.03.004_bib3","article-title":"Anti-vascular endothelial growth factor for proliferative diabetic retinopathy","volume":"3","author":"Martinez-Zapata","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.aopr.2026.03.004_bib4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00004397-198702740-00004","article-title":"Indications for photocoagulation treatment of diabetic retinopathy: diabetic retinopathy study report no. 14. The diabetic retinopathy study research group","volume":"27","year":"1987","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.aopr.2026.03.004_bib5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/08820538.2017.1353820","article-title":"Panretinal photocoagulation: a review of complications","volume":"33","author":"Reddy","year":"2018","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.aopr.2026.03.004_bib6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1600-0420.1995.tb00031.x","article-title":"Dye laser treatment in proliferative diabetic retinopathy and maculopathy","volume":"73","author":"Atmaca","year":"1995","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.aopr.2026.03.004_bib7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ajo.2011.05.035","article-title":"Panretinal photocoagulation for proliferative diabetic retinopathy: pattern scan laser versus argon laser","volume":"153","author":"Chappelow","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.aopr.2026.03.004_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/728325","article-title":"The role of angiogenesis in the development of proliferative diabetic retinopathy: impact of intravitreal anti-VEGF treatment","volume":"2012","author":"Tremolada","year":"2012","journal-title":"Exp Diabetes Res"},{"key":"10.1016\/j.aopr.2026.03.004_bib9","first-page":"20","article-title":"Intravitreal bevacizumab as anti-vascular endothelial growth factor in the management of complications of proliferative diabetic retinopathy","volume":"2","author":"Arevalo","year":"2013","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"key":"10.1016\/j.aopr.2026.03.004_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ophtha.2018.08.001","article-title":"Rationale and application of the protocol S anti-vascular endothelial growth factor algorithm for proliferative diabetic retinopathy","volume":"126","author":"Sun","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.aopr.2026.03.004_bib11","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1463-1326.2012.01584.x","article-title":"Effects of intravitreal injection of KH902, a vascular endothelial growth factor receptor decoy, on the retinas of streptozotocin-induced diabetic rats","volume":"14","author":"Huang","year":"2012","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.aopr.2026.03.004_bib12","first-page":"1437","article-title":"Recombinant anti-vascular endothelial growth factor fusion protein efficiently suppresses choridal neovasularization in monkeys","author":"Zhang","year":"2008","journal-title":"Mol Vis"},{"key":"10.1016\/j.aopr.2026.03.004_bib13","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s11095-008-9718-9","article-title":"The pharmacology study of a new recombinant human VEGF receptor-fc fusion protein on experimental choroidal neovascularization","volume":"26","author":"Zhang","year":"2009","journal-title":"Pharm Res"},{"key":"10.1016\/j.aopr.2026.03.004_bib14","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.exer.2011.09.002","article-title":"Pharmacokinetics of a long-lasting anti-VEGF fusion protein in rabbit","volume":"97","author":"Li","year":"2012","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.aopr.2026.03.004_bib15","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1136\/bjophthalmol-2020-318690","article-title":"Intravitreal conbercept for diabetic macular oedema: 2-Year results from a randomised controlled trial and open-label extension study","volume":"106","author":"Liu","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.aopr.2026.03.004_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5591719","article-title":"The effectiveness of conbercept combined with panretinal photocoagulation vs. panretinal photocoagulation in the treatment of diabetic retinopathy: a meta-analysis","volume":"2021","author":"Huang","year":"2021","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.aopr.2026.03.004_bib17","article-title":"A comparison between the therapeutic effects of conbercept combined with panretinal photocoagulation and panretinal photocoagulation monotherapy for high-risk proliferative diabetic retinopathy","volume":"13","author":"Sun","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.aopr.2026.03.004_bib18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000495423","article-title":"Single-dose intravitreal conbercept before panretinal photocoagulation as an effective adjunctive treatment in Chinese proliferative diabetic retinopathy","volume":"242","author":"Zhang","year":"2019","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.aopr.2026.03.004_bib19","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ophtha.2017.12.008","article-title":"Ranibizumab plus panretinal photocoagulation versus panretinal photocoagulation alone for high-risk proliferative diabetic retinopathy (PROTEUS study)","volume":"125","author":"Figueira","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.aopr.2026.03.004_bib20","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1001\/jama.2015.15217","article-title":"Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial","volume":"314","author":"Writing Committee for the Diabetic Retinopathy Clinical Research N","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.aopr.2026.03.004_bib21","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/S0140-6736(17)31193-5","volume":"389","author":"Sivaprasad","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.aopr.2026.03.004_bib22","doi-asserted-by":"crossref","first-page":"e795","DOI":"10.1111\/aos.14681","article-title":"Intravitreal anti-vascular endothelial growth factors, panretinal photocoagulation and combined treatment for proliferative diabetic retinopathy: a systematic review and network meta-analysis","volume":"99","author":"Fallico","year":"2021","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.aopr.2026.03.004_bib23","doi-asserted-by":"crossref","first-page":"e567","DOI":"10.1111\/j.1755-3768.2011.02184.x","article-title":"Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy","volume":"89","author":"Filho","year":"2011","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.aopr.2026.03.004_bib24","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1007\/s10792-021-01773-6","article-title":"Retrospective study of aflibercept in combination therapy for high-risk proliferative diabetic retinopathy and diabetic maculopathy","volume":"41","author":"Tao","year":"2021","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.aopr.2026.03.004_bib25","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/s41433-019-0628-3","article-title":"Longitudinal neovascular changes on optical coherence tomography angiography in proliferative diabetic retinopathy treated with panretinal photocoagulation alone versus with intravitreal conbercept plus panretinal photocoagulation: a pilot study","volume":"34","author":"He","year":"2020","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.aopr.2026.03.004_bib26","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2143082","article-title":"Intravitreal conbercept injection with and without grid laser photocoagulation in the treatment of diffuse diabetic macular edema in real-life clinical practice","volume":"2016","author":"Xu","year":"2016","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.aopr.2026.03.004_bib27","first-page":"2013","article-title":"Effect of panretinal photocoagulation on macular morphology and thickness in eyes with proliferative diabetic retinopathy without clinically significant macular edema","volume":"6","author":"Soman","year":"2012","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.aopr.2026.03.004_bib28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00006982-198500510-00002","article-title":"Macular edema following panretinal photocoagulation","volume":"5","author":"McDonald","year":"1985","journal-title":"Retina"},{"key":"10.1016\/j.aopr.2026.03.004_bib29","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0161-6420(85)34016-2","article-title":"Visual loss following panretinal photocoagulation for proliferative diabetic retinopathy","volume":"92","author":"McDonald","year":"1985","journal-title":"Ophthalmology"},{"key":"10.1016\/j.aopr.2026.03.004_bib30","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/archopht.1986.01050190055039","article-title":"Temporary loss of foveal contrast sensitivity associated with panretinal photocoagulation","volume":"104","author":"Higgins","year":"1986","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.aopr.2026.03.004_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2025.101406","article-title":"International consensuses and controversies on causes, diagnosis and management of diabetic macular edema (DME)","volume":"109","author":"Ng","year":"2025","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.aopr.2026.03.004_bib32","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1001\/jamaophthalmol.2018.3255","article-title":"Five-year outcomes of panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial","volume":"136","author":"Gross","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.aopr.2026.03.004_bib33","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/IAE.0b013e31819a5fc2","article-title":"Panretinal photocoagulation combined with intravitreal bevacizumab in high-risk proliferative diabetic retinopathy","volume":"29","author":"Cho","year":"2009","journal-title":"Retina"},{"key":"10.1016\/j.aopr.2026.03.004_bib34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10633-012-9322-5","article-title":"Electroretinographic findings associated with panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab treatment for high-risk proliferative diabetic retinopathy","volume":"124","author":"Messias","year":"2012","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.aopr.2026.03.004_bib35","doi-asserted-by":"crossref","first-page":"8778","DOI":"10.1038\/s41598-020-65833-0","article-title":"Efficacy of conbercept combined with panretinal photocoagulation in the treatment of proliferative diabetic retinopathy","volume":"10","author":"He","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.aopr.2026.03.004_bib36","doi-asserted-by":"crossref","first-page":"e530","DOI":"10.1111\/aos.14312","article-title":"Efficacy and safety of ranibizumab with or without panretinal laser photocoagulation versus laser photocoagulation alone in proliferative diabetic retinopathy - the PRIDE study","volume":"98","author":"Lang","year":"2020","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.aopr.2026.03.004_bib37","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1600-0420.2007.01056.x","article-title":"Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study)","volume":"86","author":"Tonello","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.aopr.2026.03.004_bib38","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3341\/kjo.2009.23.4.266","article-title":"Effects of an intravitreal bevacizumab injection combined with panretinal photocoagulation on high-risk proliferative diabetic retinopathy","volume":"23","author":"Shin","year":"2009","journal-title":"Kor J Ophthalmol"},{"issue":"1","key":"10.1016\/j.aopr.2026.03.004_bib39","article-title":"Regression of neovascularization after panretinal photocoagulation combined with Anti-VEGF injection for proliferative diabetic Retinopathy-A review","volume":"14","author":"Gawecki","year":"2023","journal-title":"Diagnostics (Basel)"}],"container-title":["Advances in Ophthalmology Practice and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667376226000302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667376226000302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:39:00Z","timestamp":1792265940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667376226000302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2667376226000302"],"URL":"https:\/\/doi.org\/10.1016\/j.aopr.2026.03.004","relation":{},"ISSN":["2667-3762"],"issn-type":[{"value":"2667-3762","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the efficacy and safety of conbercept plus panretinal photocoagulation versus panretinal photocoagulation alone for proliferative diabetic retinopathy: A multicenter, prospective, randomized controlled study","name":"articletitle","label":"Article Title"},{"value":"Advances in Ophthalmology Practice and Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aopr.2026.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of Zhejiang University Press.","name":"copyright","label":"Copyright"}]}}